This is so messed up. Time and time again we've seen drugs that target amyloid beta fail to have any effect, and this one is no different. Not only were the st

This is so messed up. Time and time again we've seen drugs that target amyloid beta fail to have any effect, and this one is no different. Not only were the studies inconclusive, but they were only of people with very mild Alzheimer's or even pre-alzheimers and yet the FDA is approving it for any patient with Alzheimer's. Just stealing billions of dollars from desperate people.